Skip to main content
. 2018 Apr 1;2018:9519231. doi: 10.1155/2018/9519231

Table 3.

The changes in patients' symptoms.

JTTZ group Metformin group P values
Total symptom score
Week 0 11.03 ± 4.93 10.78 ± 4.63 0.598
Week 12 5.80 ± 4.05 8.57 ± 4.40 0.000
Week 12–week 0 −5.23 ± 4.20 −2.21 ± 4.11 0.000
Paired sample t-test (P) 0.000 0.000
Symptom disappearance rate
Thoracoabdominal distension 55 (44.4%) 35 (27.8%) 0.006
Abdominal fullness 74 (54.8%) 52 (46.0%) 0.168
Constipation 62 (72.9%) 26 (31.7%) 0.000
Dry mouth 55 (33.7%) 41 (25.9%) 0.128
Bitter mouth 49 (41.2%) 33 (28.4%) 0.041
Halitosis 46 (45.1%) 18 (21.7%) 0.001
Thirst and drinking cold water 35 (29.4%) 28 (25.0%) 0.453
Increased eating with rapid hunger 57 (46.7%) 33 (30.8%) 0.014
Red tongue and yellow tongue coating 51 (29.8%) 28 (18.8%) 0.023
Power and rapid pulse 71 (50.0%) 34 (27.6%) 0.000